Why Multiplex Testing Will Become the Diagnostic Standard of Care
Though not a new diagnostic technique, multiplex testing is poised to become the standard of diagnostic care in the post-pandemic world.
Though not a new diagnostic technique, multiplex testing is poised to become the standard of diagnostic care in the post-pandemic world.
Broad-based genetic testing gives clinicians better insights into chronic kidney disease, improving the odds of a good transplant outcome.
Integra Bioscience's in-house BRB-seq service provides crucial gene expression data at a fraction of the cost and time.
Thermo Fisher’s Applied Biosystems SeqStudio Flex Series Genetic Analyzer improves research in areas such as gene editing and infectious disease.
Read MoreSPT Labtech launched a new liquid handling platform for next-generation sequencing (NGS) library preparation.
Read MoreNeoGenomics will use Thermo Fisher Scientific’s next-generation sequencing solution in a pharma-sponsored Phase 1 study of myeloid cancer.
Read MoreGenapsys CEO Jason Myers explains how his company is planning to solve return on investment and patient access with the company’s NGS platform.
Read MoreSingular Genomics Systems launched its G4 benchtop sequencer for commercial use in a range of applications, such as research in oncology and immunology.
Read MoreThe era of space exploration brings with it a new risk: invasion. But not from little green men, rather, from microbiological contamination.
Read MoreA same-day test has been shown to successfully identify secondary infections for patients on intensive care in hours rather than days.
Read MoreGenomics England recently announced a pilot program of whole genome sequencing to screen for genetic diseases in 200,000 healthy seeming newborns.
Read MoreResearchers have developed a mulitiplex network that reveals underlying mechanisms of rare diseases for more accurate identification of genetic defects.
Read MoreDeveloped by UC San Diego researchers, the SENSR tool is based on CRISPR gene-editing technology that allows speedy detection of pathogens by identifying genetic sequences in their DNA or RNA.
Read MoreWhole genome sequencing from a single blood test picks up 31% more cases of rare genetic disorders than standard tests.
Read MoreGenetic testing of the siblings of newborns with cancer genes could reduce rare pediatric cancer deaths by about 50%, an NIH-funded analysis suggests.
Read MoreResearchers have developed a new tool that could help provide early warnings of potentially deadly bacterial pathogens which cause sepsis, among other uses.
Read MoreINanoBio has successfully fabricated initial prototypes of its novel Field Effect Nanopore Transistor (FENT) device.
Read MoreNuProbe Global and Bionano Genomics have entered into a procurement and collaboration agreement, for research and product development.
Read More